Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001764013-25-000143

Chief Technology Officer sold 2,520 shares at $19.03 ($47,956)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stout Jay S Chief Technology Officer 2025-10-22 Sale −2,520 $19.03 $47,956 200,814 D
Open-market sales · 2,520 sh · avg $19.03 · $47,956
Loading xslF345X05/wk-form4_1761338213.xml…